Results 11 to 20 of about 1,565,970 (254)

CARDIOVASCULAR DISEASES IN RHEUMATOID ARTHRITIS: LATEST DATA [PDF]

open access: yesНаучно-практическая ревматология, 2016
The paper gives the latest data on the impact of traditional cardiovascular risk factors, chronic inflammation, antirheumatic therapy (disease-modifying antirheumatic drugs and biological agents) on the cardiovascular system.
T. V. Popkova   +2 more
doaj   +2 more sources

Updated American College of Rheumatology/American Association of Hip and Knee Surgeons guideline for the perioperative management of antirheumatic medication in patients with rheumatic diseases undergoing elective total hip or total knee arthroplasty 2022

open access: yesНаучно-практическая ревматология, 2023
The article presents updated guidelines developed by the American College of Rheumatology and the American Association of Hip and Knee Surgeons on the perioperative treatment of patients with rheumatoid arthritis, ankylosing spondylitis, psoriatic ...
V. N. Amirjanova   +7 more
doaj   +2 more sources

REVIEW OF THE 2017 AMERICAN COLLEGE OF RHEUMATOLOGY/AMERICAN ASSOCIATION OF HIP AND KNEE SURGEONS GUIDELINES FOR THE PERIOPERATIVE MANAGEMENT AND ANTIRHEUMATIC THERAPY OF PATIENTS WITH RHEUMATIC DISEASES BEFORE TOTAL KNEE AND HIP ARTHROPLASTY [PDF]

open access: yesНаучно-практическая ревматология, 2018
The article presents the guidelines developed by the American College of Rheumatology and the American Association of Hip and Knee Surgeons for the perioperative management of patients with rheumatoid arthritis, ankylosing spondylitis, psoriatic ...
V. N. Amirdzhanova   +2 more
doaj   +2 more sources

Diabetes-Modifying Antirheumatic Drugs: The Roles of DMARDs as Glucose-Lowering Agents [PDF]

open access: yesMedicina, 2022
Systemic inflammation represents a shared pathophysiological mechanism which underlies the frequent clinical associations among chronic inflammatory rheumatic diseases (CIRDs), insulin resistance, type 2 diabetes (T2D), and chronic diabetes complications,
Marco Infante   +6 more
doaj   +2 more sources

DRUG SAFETY DATA COVERAGE IN MEDICAL LITERATURE [PDF]

open access: yesНаучно-практическая ревматология, 2015
The paper discusses whether it is expedient to use the standards approved by the editorial staff of a number of medical journals for original articles on the therapeutic effect of drugs, including antirheumatic agents since this is of importance for the ...
Yu. V. Muravyev, L. A. Muravyeva
doaj   +2 more sources

Real-World Trends in Prenatal Antirheumatic Drug Utilization in Ontario, Canada: A Cross-Sectional Time-Series Analysis. [PDF]

open access: yesArthritis Care Res (Hoboken)
Objective This study aimed to describe real‐world trends in preconception and prenatal use of antirheumatic drugs among pregnant individuals with rheumatic diseases in Ontario, Canada. Methods We conducted a time‐series analysis using repeated cross‐sectional data to examine annual patterns of disease‐modifying antirheumatic drug (DMARD) use among ...
Tharmarajah S   +6 more
europepmc   +2 more sources

Use of healthcare administrative claims data in observational studies of antirheumatic drug effects on pregnancy outcomes: A scoping review.

open access: yesPLoS ONE
The safety of antirheumatic drugs in pregnancy and their impact on maternal and neonatal outcomes are understudied. Despite pregnant individuals being excluded from clinical trials, their continued use of medications raises the importance of addressing ...
Shenthuraan Tharmarajah   +7 more
doaj   +2 more sources

Effects of Abatacept in patients with rheumatoid arthritis and cancer risk [PDF]

open access: yesReviews in Clinical Medicine, 2023
Introduction: As a chronic autoimmune disease, Rheumatoid arthritis (RA) affects the joints. Studies have shown a complex and challenging link between cancer and RA.
Saba Homapoor   +2 more
doaj   +1 more source

The Safety of Antirheumatic Drugs [PDF]

open access: yes, 2022
BACKGROUND: Drug therapy for rheumatic diseases has changed fundamentally in recent decades with the introduction of many new agents. As these drugs may have to be taken for many years, and many of them are of similar efficacy, the safety profiles of the
Simon, Hans-Uwe   +6 more
core   +1 more source

Efficacy and safety of tofacitinib in patients with rheumatoid arthritis by previous treatment: post hoc analysis of phase II/III trials

open access: yesArthritis Research & Therapy, 2023
Background This study sought to evaluate the efficacy and safety of tofacitinib in patients with rheumatoid arthritis with distinct treatment histories. Methods Pooled phase II/III trial data from patients who received tofacitinib 5 or 10 mg twice daily ...
John Tesser   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy